Glucagon and insulin secretion in low birthweight preterm infants. The effect of glucose infusion. 1990

S Grasso, and F Fallucca, and M G Romeo, and G Distefano, and E Sciullo, and G Reitano
Institute of Pathology, University of Catania, Italy.

The effect of the intravenous glucose on plasma levels of glucagon and insulin were evaluated in thirty-five LBW preterm infants who were appropriate for gestational age. Their mean birthweight and gestational age were 1220 +/- 55 g (range 750-1730 g) and 29 +/- 1 weeks (range 25-35 weeks), respectively. A 30 min glucose infusion in 16 infants (1 g/kg b.w. in 30 min) caused a prompt and sustained suppression of plasma glucagon and a delayed but significant insulin release. The mean of the sum of maximal plasma glucagon decrements below the baseline was 173 +/- 42 pg/ml. In another 12 infants a significant fall in plasma glucagon and a variable but significant plasma insulin release also occurred throughout the 24 h study on continuous intravenous glucose (rate 2.4-2.7 mg/kg/min). The mean of the sum of maximal plasma glucagon decrements below the baseline up to 12 h was 282 +/- 36 and was similar to that seen in the previous group.

UI MeSH Term Description Entries
D007230 Infant, Low Birth Weight An infant having a birth weight of 2500 gm. (5.5 lb.) or less but INFANT, VERY LOW BIRTH WEIGHT is available for infants having a birth weight of 1500 grams (3.3 lb.) or less. Low Birth Weight,Low-Birth-Weight Infant,Birth Weight, Low,Birth Weights, Low,Infant, Low-Birth-Weight,Infants, Low-Birth-Weight,Low Birth Weight Infant,Low Birth Weights,Low-Birth-Weight Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Grasso, and F Fallucca, and M G Romeo, and G Distefano, and E Sciullo, and G Reitano
April 1988, Midwife, health visitor & community nurse,
S Grasso, and F Fallucca, and M G Romeo, and G Distefano, and E Sciullo, and G Reitano
December 1974, Diabetologia,
S Grasso, and F Fallucca, and M G Romeo, and G Distefano, and E Sciullo, and G Reitano
January 1977, The Journal of clinical endocrinology and metabolism,
S Grasso, and F Fallucca, and M G Romeo, and G Distefano, and E Sciullo, and G Reitano
March 1979, Endocrinology,
S Grasso, and F Fallucca, and M G Romeo, and G Distefano, and E Sciullo, and G Reitano
June 1975, Diabetologia,
S Grasso, and F Fallucca, and M G Romeo, and G Distefano, and E Sciullo, and G Reitano
June 2000, Periodontology 2000,
S Grasso, and F Fallucca, and M G Romeo, and G Distefano, and E Sciullo, and G Reitano
January 1995, The American journal of physiology,
S Grasso, and F Fallucca, and M G Romeo, and G Distefano, and E Sciullo, and G Reitano
January 1990, Acta paediatrica Scandinavica,
S Grasso, and F Fallucca, and M G Romeo, and G Distefano, and E Sciullo, and G Reitano
September 1995, American journal of perinatology,
S Grasso, and F Fallucca, and M G Romeo, and G Distefano, and E Sciullo, and G Reitano
November 1988, Acta paediatrica Scandinavica,
Copied contents to your clipboard!